| PERIOD ENDING | 31-Jul-09 | 1-May-09 | 30-Jan-09 | 31-Oct-08 | | Total Revenue | 12,764,000 | 12,342,000 | 13,428,000 | 15,162,000 | | Cost of Revenue | 10,373,000 | 10,174,000 | 11,116,000 | 12,309,000 | | | Gross Profit | 2,391,000 | 2,168,000 | 2,312,000 | 2,853,000 | | | Operating Expenses | | Research Development | 149,000 | 141,000 | 176,000 | 167,000 | | Selling General and Administrative | 1,571,000 | 1,613,000 | 1,679,000 | 1,671,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 671,000 | 414,000 | 457,000 | 1,015,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) | 27,000 | 24,000 | 60,000 | | Earnings Before Interest And Taxes | 668,000 | 441,000 | 481,000 | 1,075,000 | | Interest Expense | 39,000 | 29,000 | 27,000 | 66,000 | | Income Before Tax | 629,000 | 412,000 | 454,000 | 1,009,000 | | Income Tax Expense | 157,000 | 122,000 | 103,000 | 282,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 472,000 | 290,000 | 351,000 | 727,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 472,000 | 290,000 | 351,000 | 727,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $472,000 | $290,000 | $351,000 | $727,000 |
|
0.22% Nasdaq 
Income Statement
